Scarica l'app Stockscreener
22.79
0.18%
0.04
Dopo l'orario di chiusura:
22.79
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché FMS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$22.75
Aprire:
$22.9
Volume 24 ore:
409.09K
Relative Volume:
0.70
Capitalizzazione di mercato:
$12.73B
Reddito:
$22.18B
Utile/perdita netta:
$1.36B
Rapporto P/E:
11.86
EPS:
1.9216
Flusso di cassa netto:
$2.00B
1 W Prestazione:
-0.70%
1M Prestazione:
-6.75%
6M Prestazione:
-8.73%
1 anno Prestazione:
-1.64%
Intervallo 1D:
$22.71
$22.97
Intervallo di 1 settimana:
$22.62
$23.51
Portata 52W:
$20.95
$30.46
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Nome
Fresenius Medical Care Ag Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare FMS vs HCA, THC, ENSG, UHS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
22.79 | 12.73B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
HCA
Hca Healthcare Inc
|
532.97 | 119.18B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
227.63 | 19.80B | 21.31B | 2.37B | 2.53B | 15.49 |
|
ENSG
Ensign Group Inc
|
209.71 | 12.19B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
192.42 | 11.75B | 17.36B | 1.51B | 849.25M | 23.15 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Downgrade | Goldman | Buy → Neutral |
| 2025-10-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-09-02 | Downgrade | UBS | Neutral → Sell |
| 2024-12-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-11-06 | Iniziato | Berenberg | Buy |
| 2024-01-08 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-11-17 | Aggiornamento | Societe Generale | Hold → Buy |
| 2023-08-14 | Downgrade | UBS | Buy → Neutral |
| 2023-08-01 | Ripresa | Citigroup | Neutral |
| 2023-07-12 | Iniziato | Goldman | Buy |
| 2023-03-07 | Iniziato | Bernstein | Mkt Perform |
| 2023-01-03 | Downgrade | Jefferies | Buy → Underperform |
| 2022-10-26 | Downgrade | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-10-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-06-27 | Aggiornamento | Jefferies | Underperform → Buy |
| 2022-02-11 | Downgrade | Jefferies | Hold → Underperform |
| 2021-11-23 | Iniziato | HSBC Securities | Hold |
| 2021-11-11 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-02-04 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-02-03 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2020-05-20 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-06-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | Aggiornamento | UBS | Neutral → Buy |
| 2018-08-28 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2018-07-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | Aggiornamento | UBS | Sell → Neutral |
| 2017-12-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2016-07-08 | Aggiornamento | Jefferies | Underperform → Hold |
| 2016-01-04 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2015-11-04 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2015-08-13 | Downgrade | Societe Generale | Buy → Hold |
| 2015-07-31 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | Reiterato | Feltl & Co. | Hold |
| 2013-01-14 | Aggiornamento | HSBC Securities | Neutral → Overweight |
Mostra tutto
Fresenius Medical Care Ag Adr Borsa (FMS) Ultime notizie
Fresenius Medical Care publishes its Annual Report 2025: The power of care - Fresenius Medical Care
Advancing kidney care: Introducing high-volume hemodiafiltration to the U.S. - Fresenius Medical Care
Fresenius Medical Care Faces a Transition Year in 2026 on New Product Launch Activities - Morningstar
Fresenius Medical Care marks World Kidney Day and National Kidney Month - Fresenius Medical Care
Fresenius Medical Care: An Undervalued Stock to Buy Now and Hold for the Long Term - Morningstar
5 Undervalued Stocks That Crushed Q4 Earnings - Morningstar
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand - Finviz
Research in brief: Nocturnal home hemodialysis - Fresenius Medical Care
Fresenius Medical Care ADR earnings beat by $1.11, revenue topped estimates - Investing.com Australia
Fresenius Medical Care published Report on Form 20-F for fiscal year 2025 - Fresenius Medical Care
Fresenius Medical Care Q4 2025 slides: margin surge, flat 2026 outlook - Investing.com
Earnings call transcript: Fresenius Medical Care Q4 2025 beats EPS expectations - Investing.com
Fresenius Medical Care falls nearly 7% despite earnings beat - Investing.com South Africa
Fresenius Medical Care falls 7% after 2026 flat growth outlook and cost update - Investing.com
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band - Fresenius Medical Care
Uncovering Potential: Fresenius Medical Care's Earnings Preview - Sahm
Research in Brief: Hemodiafiltration and hospitalization burden in ESKD - Fresenius Medical Care
FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Allstate Upgraded, Amazon Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Statement from Fresenius Medical Care on Upcoming Winter Storm - Fresenius Medical Care
Annual Press Conference 2026 - Fresenius Medical Care
18 of the Best Stocks and ETFs to Buy Based on 2026 Expert Forecasts - Morningstar
6 New 5-Star Stocks - Morningstar
Research in brief: Implementation of Online High-Volume Hemodiafiltration - Fresenius Medical Care
Goldman Sachs downgrades Fresenius Medical Care stock on 2026 headwinds By Investing.com - Investing.com South Africa
Goldman Sachs downgrades Fresenius Medical Care stock on 2026 headwinds - Investing.com
Reasons to Add Fresenius Medical Stock to Your Portfolio Now - Finviz
Fresenius Medical Care accelerates second tranche of share buyback - Investing.com
Fresenius Medical Care accelerates second tranche of share buyback By Investing.com - Investing.com India
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned - Fresenius Medical Care
Finding purpose and perseverance: A dialysis nurse’s quiet heroism - Fresenius Medical Care
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now - Finviz
Fresenius Medical Care names Charles Hugh-Jones as new global CMO By Investing.com - Investing.com South Africa
Fresenius Medical Care names Charles Hugh-Jones as new global CMO - Investing.com India
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board - Fresenius Medical Care
DoorDash Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Research in brief: Time on treatment - Fresenius Medical Care
Alphabet Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Fresenius Medical Care Ag Adr Azioni (FMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.65%
1.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):